Form 4: Guardant Health Director Ian T. Clark Reports Acquisition of Common Stock from RSU Conversion

Guardant Health Director Ian T. Clark reported the acquisition of 8,088 shares of common stock through the conversion of restricted stock units, increasing his indirect beneficial ownership.

Summary

• Ian T. Clark, a Director of Guardant Health, Inc. (GH), reported a transaction on June 12, 2025.
• The transaction involved the acquisition of 8,088 shares of Guardant Health Common Stock.
• These shares were acquired through the conversion of Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this transaction, Ian T. Clark's indirect beneficial ownership, held by The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account, increased to 16,523 shares.
• The Restricted Stock Units vested in full on the one-year anniversary of the grant date, June 12, 2024, or the date of the next annual stockholders meeting, whichever was earlier.

Sentiment

Score: 7

Explanation: The filing reports a routine insider transaction involving the conversion of Restricted Stock Units into common stock, which is a pre-scheduled compensation event for a director. This indicates continued alignment of the director's interests with shareholders, which is a neutral to slightly positive signal.

Positives

• The acquisition of shares by a director, even through RSU conversion, indicates continued alignment of management's interests with shareholder value.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

• The reported transaction involves the conversion of Restricted Stock Units (RSUs) into common stock for a director, which is a standard form of compensation and considered a related party transaction.

Stakeholder Impact

• Shareholders: The transaction increases the indirect beneficial ownership of a director, aligning management interests with shareholder value.

Key Dates

Keywords

Guardant Health, GH, Ian T. Clark, Form 4, SEC filing, insider transaction, stock acquisition, restricted stock units, RSU, director, beneficial ownership